Rafael Holdings, Inc. logo

RFL Earnings Date: Dec 10, 2026 (Estimated) — Rafael Holdings, Inc.

NYSE · Real Estate · Real Estate Services

Updated

Price $1.12
Market Cap $57.4M
P/E -1.9
52W Range $1.08 – $3.96
Next Earnings · After close (est.)

When is RFL's next earnings date?

Rafael Holdings, Inc. (RFL) is expected to report Q1 2027 earnings on Thursday, December 10, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company.

How did RFL do in its last earnings report?

In its most recent report on Oct 29, 2026 (Q4 2026), Rafael Holdings, Inc. posted EPS of -$0.18. Revenue was $244,000.

How much does RFL stock move after earnings?

Over the last 7 reports the stock moved an average of 3.7% (up or down) in the day after earnings.

About Rafael Holdings, Inc.

Rafael Holdings, Inc. holds strategic investments in both early-stage and clinical pharmaceutical companies, alongside a portfolio of commercial real estate assets situated in the United States and Israel. The company's business activities are structured into two primary divisions: Pharmaceuticals and Real Estate. Its Real Estate segment manages and leases a commercial office complex, which features an integrated 800-space public parking facility. The Pharmaceutical division, conversely, focuses on developing and bringing to market therapies designed to capitalize on the metabolic distinctions between healthy cells and malignant ones. The firm's flagship drug candidate is CPI-613 (devimistat), currently undergoing evaluation in numerous clinical trials, including two pivotal Phase III registrational studies for the treatment of advanced pancreatic cancer and relapsed/refractory acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

🤖 AI Earnings Analysis

FDA submission of Trappsol Cyclo for Niemann-Pick disease is the pivotal catalyst, but approval remains uncertain. Q4 revenue was just $244,000 and EPS was -$0.18, underscoring the pre-commercial, high-risk profile.

AI-generated summary — powered by BigEarnings.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-10-29Q4 2026—-0.18—$244,000————
2026-06-11Q3 2026—-0.08—$179,000—+19.10%+47.75%+26.97%
2026-03-16Q2 2026—-0.13—$211,000—+0.76%-3.82%-6.87%
2025-12-11Q1 2026—-0.19—$240,000—-2.01%-16.78%-16.78%
2025-10-29Q4 2025—-0.28—$350,000—+0.75%-0.75%-11.94%
2025-03-13Q2 2025—-0.19—$77,000—+1.67%+8.89%-5.56%
2024-12-11Q1 2025—-0.37—$128,000—+1.59%-9.52%-0.53%
2024-11-06Q4 2024—-0.19—$165,000—+0.00%-5.26%+1.05%

Showing last 8 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .